Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › R&D spending
Harvard Apparatus Regenerative Technology (HRGN) R&D spending by quarter
Harvard Apparatus Regenerative Technology's R&D spending was $948K in Q2 2026 (second quarter 2026), +68% from Q1 2026. Over the last 7 quarters it ranged from $271K (Q4 2024) to $948K (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $948K | +68% | +36% |
| Q1 2026 | $563K | -20% | -6% |
| Q4 2025 | $700K | +7% | +158% |
| Q3 2025 | $655K | -6% | — |
| Q2 2025 | $697K | +16% | — |
| Q1 2025 | $601K | +122% | — |
| Q4 2024 | $271K | — | — |
Q2 2026 at a glance
Harvard Apparatus Regenerative Technology, Q2 2026: revenue $414K (+31% year over year), operating margin -408.7%, net loss $1.7M, operating cash flow −$569K. The chart follows the revenue to costs, profit and cash.
Questions
What is Harvard Apparatus Regenerative Technology's R&D spending?
Harvard Apparatus Regenerative Technology's R&D spending was $948K in Q2 2026 (second quarter 2026), +68% from Q1 2026.
How has Harvard Apparatus Regenerative Technology's R&D spending changed?
Over the last 7 quarters it ranged from $271K (Q4 2024) to $948K (Q2 2026).
Q2 2026 results → · How Harvard Apparatus Regenerative Technology makes money →